Top Page
Health In Tech, Inc. Class A
(NASDAQ:HIT)
Health In Tech, Inc. Class A (HIT) vs. S&P 500 (SPY)
Health In Tech, Inc. Class A Business Overview & Revenue Model
Health In Tech, Inc. Class A Financial Statement Overview
| Breakdown | ||
| Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|
| Income Statement | Total Revenue | |
| 19.49M | 19.15M | 5.77M | Gross Profit |
| 15.44M | 16.85M | 5.44M | EBIT |
| 989.90K | 3.38M | 205.58K | EBITDA |
| 1.93M | 3.76M | 205.58K | Net Income Common Stockholders |
| 670.48K | 2.48M | 79.74K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |
| 7.85M | 2.42M | 1.49M | Total Assets |
| 15.77M | 11.50M | 28.56M | Total Debt |
| 206.69K | 1.92M | 316.09K | Net Debt |
| -7.64M | -501.18K | -1.17M | Total Liabilities |
| 2.60M | 5.41M | 27.14M | Stockholders Equity |
| 13.17M | 6.09M | 1.05M |
| Cash Flow | Free Cash Flow | |
| 1.28M | 384.52K | -436.63K | Operating Cash Flow |
| 2.18M | 1.53M | 782.75K | Investing Cash Flow |
| -836.75K | -1.94M | -1.22M | Financing Cash Flow |
| 4.09M | 1.34M | 1.88M |
Health In Tech, Inc. Class A Risk Analysis
Health In Tech, Inc. Class A Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $8.02M | 32.49 | 10.50% | ― | 11.25% | -40.66% | |
60 Neutral | $10.94B | 10.48 | -7.04% | 2.99% | 7.55% | -12.20% | |
50 Neutral | $25.33M | 31.58 | 2.02% | ― | -47.08% | -59.18% | |
47 Neutral | $6.32M | ― | -106.89% | ― | -60.68% | 96.58% | |
39 Underperform | $10.00M | ― | -34.59% | ― | -78.87% | 85.62% |
Health In Tech, Inc. Class A Earnings Call Summary
Health In Tech, Inc. Class A Corporate Events
On April 12, 2025, Lynn Liang announced her resignation from the Board of Directors of Health In Tech, Inc., effective April 18, 2025, due to other professional and personal commitments. Subsequently, on April 16, 2025, the Board decided to reduce its size from seven to six directors, also effective April 18, 2025.
Spark’s Take on HIT Stock
According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.
Health In Tech, Inc. demonstrates strong financial growth and strategic initiatives, particularly in revenue and cash flow. However, challenges with declining margins and a high P/E ratio present risks. Technical indicators suggest caution in the short term, though strategic investments and leadership expansions could support future growth.
To see Spark’s full report on HIT stock, click here.
On April 14, 2025, Health In Tech, Inc. prepared an investor presentation to be presented at conferences and meetings. The presentation highlights the company’s innovative approach to healthcare through AI-powered platforms that automate medical underwriting and broker quoting, significantly reducing the time to generate bindable quotes. This advancement is expected to enhance operational efficiency, lower costs, and improve accessibility and transparency in the healthcare market, particularly benefiting small businesses by offering competitive and customizable health plans.
Spark’s Take on HIT Stock
According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.
Health In Tech, Inc. has demonstrated strong financial growth and strategic initiatives, though operational inefficiencies and high valuation pose risks. The company’s strategic investments, leadership expansion, and technological advancements are poised to support future growth. However, current technical indicators suggest caution in the short term.
To see Spark’s full report on HIT stock, click here.
On April 14, 2025, Health In Tech announced its financial results for the first quarter of 2025, reporting a 56% increase in revenue to $8.0 million compared to the same period in 2024. The company also saw a significant rise in income before taxes, which more than tripled to $0.7 million. This growth is attributed to strategic investments made in 2024, including innovations in product development and market expansion. Additionally, Health In Tech announced a strategic collaboration with DialCare to integrate telehealth services into its offerings and appointed Sanjay Shrestha to its Board of Directors, enhancing its strategic vision for long-term growth.
Spark’s Take on HIT Stock
According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.
Health In Tech, Inc. has demonstrated strong financial growth and strategic initiatives, though operational inefficiencies and high valuation pose risks. The company’s strategic investments, leadership expansion, and technological advancements are poised to support future growth. However, current technical indicators suggest caution in the short term.
To see Spark’s full report on HIT stock, click here.
On April 8, 2025, Health In Tech, Inc. expanded its Board of Directors from six to seven members, appointing Sanjay Shrestha as a new independent director. Shrestha, who brings extensive experience from the energy and technology sectors, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. His appointment is expected to support Health In Tech’s vision of reducing friction in the U.S. healthcare system through digital innovation. The company announced this appointment on April 10, 2025, highlighting Shrestha’s leadership in scaling platform businesses and his role in advancing the green hydrogen economy at Plug Power.
On March 17, 2025, Health In Tech, Inc. prepared an investor presentation to be presented at conferences and meetings, highlighting their innovative solutions in the healthcare insurance industry. The presentation emphasized the company’s use of AI and digital innovation to streamline processes, reduce costs, and enhance transparency in the healthcare market, particularly for small businesses. This strategic focus is expected to position Health In Tech as a key player in transforming the $4.5 trillion healthcare industry by addressing market challenges and leveraging technology to offer competitive and efficient insurance solutions.
Health In Tech announced its financial results for the fourth quarter and full year ending December 31, 2024, reporting total audited revenue of $19.5 million for 2024. Despite a slight increase in revenue, the company experienced a decrease in gross margin and income from continuing operations compared to the previous year. The company completed its IPO in December 2024, raising $9.2 million, and announced a collaboration with MARPAI and Vitable DPC to enhance self-funded health plan solutions. Health In Tech is expanding its market reach by launching a mid-sized business underwriting solution and a new stop-loss product, aiming to drive revenue growth and expand its total addressable market.